Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
Authors:
Open Access
- 9 June 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (1) , 48-54
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 27 references indexed in Scilit:
- Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probesHistopathology, 2008
- Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancerCancer Letters, 2008
- Triple negative tumours: a critical reviewHistopathology, 2007
- A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancerBritish Journal of Cancer, 2006
- A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine statusJournal of Cancer Research and Clinical Oncology, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI: Journal of the National Cancer Institute, 1994